Nanoparticle Reduces Targeted Cancer Drug's Toxicity (IMAGE)

American Association for the Advancement of Science (AAAS)

Nanoparticle Reduces Targeted Cancer Drug's Toxicity

Caption

The polymeric nanoparticle Accurin encapsulates the clinical candidate AZD2811, an Aurora B kinase inhibitor. This material relates to a paper that appeared in the Feb. 10, 2016 issue of Science Translational Medicine, published by AAAS. The paper, by S. Ashton at institution in location, and colleagues was titled, "Aurora kinase inhibitor nanoparticles target tumors with favorable therapeutic index in vivo."

Credit

Ashton et al., Science Translational Medicine (2016)

Usage Restrictions

Please cite the owner of the material when publishing. This material may be freely used by reporters as part of news coverage, with proper attribution. Non-reporters must contact Science for permission.

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.